Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
about
Postoperative reactive lymphadenitis: A potential cause of false-positive FDG PET/CTClinical Utility of Positron Emission Tomography Magnetic Resonance Imaging (PET-MRI) in Gastrointestinal CancersFDG PET/CT in carcinoma of unknown primaryMonitoring Therapeutic Response in a Case of Extrapulmonary Tuberculosis by Serial F-18 FDG PET/CT.Lymph node tuberculosis mimicking malignancy on 18F-FDG PET/CT in two patients: A case report.124I-HuCC49deltaCH2 for TAG-72 antigen-directed positron emission tomography (PET) imaging of LS174T colon adenocarcinoma tumor implants in xenograft mice: preliminary results.Perceived misinterpretation rates in oncologic 18F-FDG PET/CT studies: a survey of referring physiciansApplications of molecular imaging.Association of esophageal inflammation, obesity and gastroesophageal reflux disease: from FDG PET/CT perspectiveReal-time FDG PET guidance during biopsies and radiofrequency ablation using multimodality fusion with electromagnetic navigation.Paget's disease of pelvis mimicking metastasis in a patient with lung cancer evaluated using staging and follow-up imaging with fluorine-18 fluorodeoxyglucose-positron emission tomography/computed tomography.(18)F-FDG-PET/CT in the assessment of pulmonary solitary nodules: comparison of different analysis methods and risk variables in the prediction of malignancy.Multifocal musculoskeletal tuberculosis mimicking multiple bone metastases: a case report.Fluro-deoxygenase-positron emission tomography/computed tomography in hard metal lung disease.18F-fluoro-deoxyglucose positron emission tomography/computed tomography scan findings in Rosai-Dorfman disease with IgG4-positive plasma cell infiltration mimicking breast malignancy: a case report and literature review.The value of intratumoral heterogeneity of (18)F-FDG uptake to differentiate between primary benign and malignant musculoskeletal tumours on PET/CT.Clinical utility of ¹⁸F FDG-PET/CT in the detection of bone marrow disease in Hodgkin's lymphoma.A pilot study of the value of 18F-fluoro-deoxy-thymidine PET/CT in predicting viable lymphoma in residual 18F-FDG avid masses after completion of therapy.A Comparison Study of Esophageal Findings on (18)F-FDG PET/CT and EsophagogastroduodenoscopyFalse-positive Uptake on Positron Emission Tomography/Computed Tomography Immediately After Lung Biopsy: A Case Report.Role of (18)F-FDG PET Scan in Rheumatoid Lung Nodule: Case Report and Review of the Literature.Focal FDG Uptake in Lung Parenchyma Without Structural Alterations on CTMultimodal imaging and detection strategy with 124 I-labeled chimeric monoclonal antibody cG250 for accurate localization and confirmation of extent of disease during laparoscopic and open surgical resection of clear cell renal cell carcinoma.Highly metabolic thrombus of the portal vein: 18F fluorodeoxyglucose positron emission tomography/computer tomography demonstration and clinical significance in hepatocellular carcinomaDiagnostic usefulness of an amino acid tracer, α-[N-methyl-(11)C]-methylaminoisobutyric acid ( (11)C-MeAIB), in the PET diagnosis of chest malignancies.PET and SPECT Imaging of Tumor Biology: New Approaches towards Oncology Drug Discovery and Development.Brain: normal variations and benign findings in fluorodeoxyglucose-PET/computed tomography imaging.Positron emission tomography findings in clinical mimics of lymphoma.PET/CT imaging in systemic lupus erythematosus.FDG-PET/CT pitfalls in oncological head and neck imaging.Physiologic variants, benign processes, and artifacts from 106 canine and feline FDG-PET/computed tomography scans.Radiology of epiploic appendages: acute appendagitis, post-infarcted appendages, and imaging natural history.Current clinical status of 18F-FLT PET or PET/CT in digestive and abdominal organ oncology.Validation of automatic target volume definition as demonstrated for 11C-choline PET/CT of human prostate cancer using multi-modality fusion techniquesRadiotherapy volume delineation using dynamic [18F]-FDG PET/CT imaging in patients with oropharyngeal cancer: a pilot study.Pitfalls in interpretation of FDG PET/CT: Septic pulmonary emboli mimicking metastases in a case of gastric carcinoma.Peripheral Tuberculous Lymphadenitis Masquerading as Metastatic Gastric Carcinoma on F-18 FDG Dual Time Point PET/CT.All That Glitters Is Not Gold" - A Case of an Occult Foreign Body in the Lung with Elevated 2-[18F]-Fluoro-2-deoxy-D-glucose (FDG) Uptake Mimicking Bronchogenic Carcinoma.An intense F-FDG pulmonary microfocus on PET without detectable abnormality on CT: A manifestation of an iatrogenic FDG pulmonary embolus.FDG PET/CT Features of Hemostatic Absorbable Gelatin (Gelfoam).
P2860
Q26852220-46A851DA-2351-4A40-90EB-2D8A30DD8491Q28074096-8D117F3A-5C96-4D8A-BA67-54412622FB98Q33654392-92CB2C51-6324-4377-8B85-144C65282298Q33704254-79632FE7-73BA-465D-99A4-9DFC890BA550Q33744380-B52932BE-1083-4192-AFD5-91CDFA277AD4Q34075225-75DBA5A5-020A-4366-A0E3-091A188DB131Q35073488-4EA49AC6-D8F4-479C-BB19-C99B47242CB5Q35082412-BCB2A7AB-1C02-44D1-BB39-13A380D3FAB0Q35124027-84FCC202-FE38-42FA-9B52-50634E5BBCC2Q35167410-E78D5B1D-5BE7-4A42-8E95-2E755549896FQ35233077-70A7E0F1-7B2D-42C1-9034-C8A6E82F2E55Q35790143-40436C23-D4D9-42E9-93C0-676AE601D787Q35907907-C7C552AD-DAA3-4BAE-A2AF-9AE4C04C4B67Q36103445-67201867-6ACA-4CE4-9430-52CD0C16A706Q36498962-90B2EAFC-7305-477E-86C1-C3D0403773F4Q36550616-132B6714-2D82-4D8E-BCA0-14BDB928EB2AQ36653336-AA55F1F0-3C8E-40F1-A077-9FDDDDA1EBFBQ36816955-997D3907-C627-474E-90E6-3FA1C32712E9Q36910261-E5566B3B-1779-4D6F-8096-4A04606AD8A8Q37026146-9DA86630-F40D-47C9-B935-6B29302D89D0Q37091028-914B0729-DEBF-4868-B11F-65CB5ADCC3B6Q37100381-FF631489-5398-4A67-A353-D320E534B732Q37134628-8C825644-DF6D-4F1C-869C-53BB9E066B11Q37212938-5D7AA5DF-65BA-4C59-A64A-3E0735D908DAQ37314320-146DED96-81BE-4D1F-8FB9-47FBBD4EC250Q37374442-0B68CAA8-1C93-4C38-A148-48B522842C48Q37720604-DF9FD2B8-B354-4097-874B-80D46202B670Q37896130-177F77B3-C9CC-4372-9DAC-F572D32B90F7Q37896139-AFBC3519-5464-419E-8D91-46AC4E5A2948Q38243007-2DBB1E1C-2491-4EBC-84B5-19663E731C06Q38393170-CC3278E9-40CF-4CC8-A859-BA65CD316C58Q38824635-91CA231A-80A7-4694-BB89-A2F55830C7F3Q38988008-603DC5E4-DDE2-4F8B-84FC-DCD6B07074C7Q40010576-3BD9F757-D971-4504-8639-DABF385EC2FDQ40061489-AF911134-C702-4AA7-874F-EBFC53A96B26Q40072408-B1C7E138-479F-4723-AFCD-EC7491C08A02Q40221844-DF523374-6F71-4EB1-8BC2-5329BF307C11Q41788275-8F431325-D4FE-41E8-9F8C-DC166380D3BCQ41825886-BD129364-384A-44BE-B596-5FC81079ED77Q41842093-304DB3A9-B469-41CD-9D74-C1CD80A8E020
P2860
Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Increased (18)F-fluorodeoxyglu ...... ars of experience with PET/CT.
@ast
Increased (18)F-fluorodeoxyglu ...... ars of experience with PET/CT.
@en
type
label
Increased (18)F-fluorodeoxyglu ...... ars of experience with PET/CT.
@ast
Increased (18)F-fluorodeoxyglu ...... ars of experience with PET/CT.
@en
prefLabel
Increased (18)F-fluorodeoxyglu ...... ars of experience with PET/CT.
@ast
Increased (18)F-fluorodeoxyglu ...... ars of experience with PET/CT.
@en
P1476
Increased (18)F-fluorodeoxyglu ...... ars of experience with PET/CT.
@en
P2093
Einat Even-Sapir
P304
P356
10.1053/J.SEMNUCLMED.2007.01.001
P577
2007-05-01T00:00:00Z